The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetug, a potential new treatment option targeting Multiple ...
Production in Okinawa, Japan to be the first in Asia Pacific, targeting 200 million liters of ETJ SAF annually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback